Julien Coste
Financieel Directeur/CFO bij INTRASENSE
Actieve functies van Julien Coste
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
INTRASENSE | Hoofd Administratief Officier | - | - |
Financieel Directeur/CFO | - | - | |
Biovertis AG
Biovertis AG Pharmaceuticals: MajorHealth Technology Biovertis AG operates as a clinical stage pharmaceutical company. It develops small molecule drugs against proprietary microbial antigens. The firm discovers and develops antimicrobial drugs for infections caused by antibiotic-resistant bacterial pathogens. The company was founded by Erich Felber, Uwe von Ahsen, and Alexander Ullrich von Gabain in 2003 and is headquartered in Vienna, Austria. | Algemeen Directeur | 22-08-2018 | - |
Loopbaan van Julien Coste
Eerdere bekende functies van Julien Coste
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
DEINOVE | Hoofd Administratief Officier | 31-07-2012 | - |
Financieel Directeur/CFO | 31-07-2012 | - | |
Public Communications Contact | 31-07-2012 | - | |
Neuro3D SA
Neuro3D SA Pharmaceuticals: OtherHealth Technology Neuro3d SA develops pharmaceutical products to treat the central nervous system. Neuro3d has a full pipeline of innovative compounds with new mechanisms of action that have the potential to overcome the limitations of current drug therapies. It leads compound, the atypical antipsychotic ocaperidone, is being investigated in two international double-blind Phase II trials for treatment of schizophrenia. The company was founded in November 2000 and is headquartered in Mulhouse, France. | Hoofd Administratief Officier | - | - |
Financieel Directeur/CFO | - | - |
Opleiding van Julien Coste
Ecole Superieure Commerce Grenoble Business School | Undergraduate Degree |
Université Paris Dauphine-PSL | Graduate Degree |
Statistieken
Internationaal
Frankrijk | 6 |
Oostenrijk | 2 |
Operationeel
Chief Administrative Officer | 3 |
Director of Finance/CFO | 3 |
Public Communications Contact | 1 |
Sectoraal
Health Technology | 4 |
Consumer Services | 3 |
Technology Services | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Beursgenoteerde bedrijven | 1 |
---|---|
INTRASENSE | Technology Services |
Bedrijven in privébezit | 3 |
---|---|
Neuro3D SA
Neuro3D SA Pharmaceuticals: OtherHealth Technology Neuro3d SA develops pharmaceutical products to treat the central nervous system. Neuro3d has a full pipeline of innovative compounds with new mechanisms of action that have the potential to overcome the limitations of current drug therapies. It leads compound, the atypical antipsychotic ocaperidone, is being investigated in two international double-blind Phase II trials for treatment of schizophrenia. The company was founded in November 2000 and is headquartered in Mulhouse, France. | Health Technology |
Deinove SA
Deinove SA BiotechnologyHealth Technology Deinove SA is a biotechnology company, which engages in the development of new-generation anti-infective antibiotics and bioactives. Its portfolio include Phy-N-Resist and HEBELYS. The company was founded by Philippe Pouletty and Miroslav Radman on October 11, 2006 and is headquartered in Grabels, France. | Health Technology |
Biovertis AG
Biovertis AG Pharmaceuticals: MajorHealth Technology Biovertis AG operates as a clinical stage pharmaceutical company. It develops small molecule drugs against proprietary microbial antigens. The firm discovers and develops antimicrobial drugs for infections caused by antibiotic-resistant bacterial pathogens. The company was founded by Erich Felber, Uwe von Ahsen, and Alexander Ullrich von Gabain in 2003 and is headquartered in Vienna, Austria. | Health Technology |
- Beurs
- Insiders
- Julien Coste
- Ervaring